Measurement of Disease Activity in Ecuadorian Patients with Rheumatoid Arthritis: Does RAPID3 Correlate with Traditional Indexes?

Table 1

Demographic and clinical information of studied population.

Characteristics	Patients (n=200) n (SD, %)
Age (years)	55.4 (13.5)
Years with rheumatoid arthritis	8.8 (7.0)
Gender
Male	29 (14.5)
Female	171 (85.5)
Serology
Seropositive	166 (83.0)
Seronegative	34 (17.0)
Comorbidities
Arterial hypertension	55 (27.5)
Type 2 DM	29 (14.5)
Hyperlipidemia	30 (15)
Osteoporosis	84 (42.0)
BMI	27.9 (4.5)
Treatment
Conventional-DMARDs	196 (98.0)
Biologics	72 (36.0)
Corticosteroids	165 (82.5)
Tofacitinib	16 (8.0)

Notes: Type 2 DM, type 2 diabetes mellitus; BMI, body mass index, DMARD, disease-modifying antirheumatic drugs.